ChemBridge Corporation Enters into new Discovery Chemistry Strategic Alliance with AstraZeneca
News Sep 25, 2008
ChemBridge Corporation has announced new multi-year research collaboration in discovery chemistry with AstraZeneca. This new alliance follows the previous collaboration between ChemBridge and AstraZeneca that was established in 2006 and successfully completed earlier this year ahead of schedule.
In accordance with the new agreement scientists from ChemBridge and AstraZeneca will work together to design and develop a new generation of highly advanced, research intensive small molecule libraries that further enhance AstraZeneca's global drug discovery effort. Further details and financial terms were not disclosed.
"We are very pleased to enhance and extend our strategic relationship with AstraZeneca, one of the world's leading pharmaceutical companies, and to continue to build upon our track record of successful teamwork with AstraZeneca," said Eugene Vaisberg, Chairman and CEO of ChemBridge Corporation and ChemBridge Research Laboratories, Inc. (CRL).
"This major new deal, which is focused on the most challenging custom compound libraries, is further proof of ChemBridge's capabilities to succeed in the increasingly competitive global discovery chemistry outsourcing market by targeting its high-end segment and leveraging the skills, expertise and experience of ChemBridge's scientists,” Vaisberg said.
New Studies Demonstrate Risk Reduction Potential of Heat-Not-Burn Tobacco Products and e-CigarettesNews
Data presented at the Society of Toxicology Annual Meeting (SOT) have demonstrated the potential of two different heat-not-burn tobacco products and e-cigarettes to reduce the risk of smoking-related diseases, in comparison to continued use of conventional cigarettes.READ MORE
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE
Moving Toward a Future Free of Drug-Induced Hearing LossNews
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018